Source: http://lawsdocbox.com/Politics/71073292-Intellectual-property-in-wto-dispute-settlement.html
Timestamp: 2019-03-22 18:49:18
Document Index: 712312192

Matched Legal Cases: ['Art.30', 'Art.30', 'Art.30', 'Art.15', 'Art.17', 'Art.5', 'Art.41', 'Art.1', 'Art.2', 'Art.1', 'Art.5', 'Art.21', 'Art.25', 'Art.22', 'Art.8', 'Art.17', 'Art.27', 'Art.13', 'Art.7', 'Art.8', 'Art.41']

Intellectual Property in WTO Dispute Settlement - PDF
Download "Intellectual Property in WTO Dispute Settlement"
1 Intellectual Property and the Judiciary 17 th EIPIN Congress Strasbourg, 30 January 2016 Intellectual Property in WTO Dispute Settlement Roger Kampf WTO Secretariat The views expressed are personal and cannot be attributed to the WTO, its Secretariat, or any of its Member governments. 1
2 I. The WTO DS Mechanism: An Overview 2
3 To deal with disputes between governments about compliance with WTO agreements and commitments, including TRIPS WTO is not a policeman System designed to ensure the rule of law in international trade relations Impartial and effective resolution of disputes Preferably out of court Objectives Governments are committed To have recourse to, and abide by, WTO DS procedures To determine violation only in accordance with these procedures To retaliate only when authorized by DSB 3
4 Overall Statistics (November 2015) Requests for consultations: 500 Mutually agreed solutions: 110 Panels established: 237/289 Panels composed: 202/249 Panel reports adopted: 165 Appellate Body reports adopted: 105 Compliance panels: 30 Appeals of compliance panels: 22 Arbitrations on "retaliation" : 19 Authorizations to "retaliate" : 18 4
5 Trends in Use of DS Mechanism 5
6 Complaints According to Agreement at Issue 6
7 TRIPS Statistics (November 2015) 34 complaints in 24 separate matters: 14 settlements 10 panel and 3 AB reports adopted 5 panels established 2 consultations pending 3 inactive Represents about 7 % of 500 complaints Most cases between developed countries Developing countries as respondents in 9 cases: 5 settlements 4 panel / 1 AB report (adopted in 1998) Developing countries and transition economies as complainants in 7 cases initiated since 2010 Good overall compliance record 7
8 II. TRIPS and IP in WTO Jurisprudence: Selected Cases and Their Broader Context 8
9 Canada Patent Protection of Pharmaceutical Products (DS114) Panel addresses claimed interest in compensatory patent term extensions: Legitimate interests" concept in Art.30 not to be used to decide normative policy issue that is still a matter of unresolved political debate Panel report: Found that stockpiling exception not limited and therefore IPR does not Jurisprudence fall under Art.30 & Confirmed that regulatory review exception meets all three conditions Ongoing and qualifies Policy as Debate Art.30 exception Report led to: Repeal of stockpiling exception in Canada Introduction of regulatory review exception as TRIPSconsistent flexibility in a range of WTO Members, including the EU 9
10 US Sect. 211 Appropriations Act (DS176) Panel discussed «other grounds for denying trademark registration» (Art.15.2 TRIPS): May include grounds not specifically mentioned in TRIPS/Paris Convention Members may deny trademark registration because applicant is not owner as defined in domestic legal system Risk of abuse by national legislation that arbitrarily IPRs & Confiscation regulates IPR ownership, but: good faith principle controls exercise of rights by states Panel findings upheld by AB report: Right to determine conditions for filing and registration of trademarks includes right to determine conditions to refuse acceptance of filing and registration on grounds other than those explicitly prohibited by Paris Convention 10
11 China - Protection and Enforcement of IPRs (WT/DS362) Addresses interface copyright public interests: Copyright protects private rights, government censorship addresses public interests Balanced approach to censorship (positive v negative rights): Copyright & Government s right to control the exploitation of works (Art.17 Berne Convention) includes censorship for reasons of public order Public Interest But: complete denial of all copyright protection and enforcement to works not authorized for publication / distribution inconsistent with Art.5(1) Berne, Art.41.1 Other relevant findings: Thresholds for criminal procedures and sanctions in particular: meaning of on a commercial scale Disposal of IPR-infringing goods confiscated by Customs authorities 11
12 US Large Civil Aircraft (DS353) Panel Report AB Report No jurisdiction on question whether or not allocation of patent rights constitutes a subsidy (Art.1 SCM) Based on arguendo assumption that allocation of patent rights is a subsidy: not specific to a particular industry (Art.2 SCM) Reasoning: uniform allocation of IPRs under all US Government R&D contracts for all enterprises in all sectors (Bayh-Dole Act (1980) & subsequent measures) IPRs & Public Policies to Fund R&D Finds arguendo approach problematic Concurs with specificity analysis 21.5 Panel New Patent Licence Agreements notified by US EU: measures taken fail to eliminate subsidy! Broader implications for public policies to fund R&D? 12
13 Australia - Plain Packaging Bill (DS434/435/441/458/467) IPRs? & Public Health
14 EU and Member State Seizure of Generic Drugs in Transit (DS408/409) Measure at issue: EU Customs Regulation 1383/2003 and other EU / Dutch legislative provisions, as well as Dutch Court decisions goes beyond TRIPS requirements, as applicable to goods in transit and patent infringing goods Legal arguments in WTO DS consultations: Alleged violations in DS consultations include GATT (Art.V), TRIPS (Art.1.1, 7, 8, 31, 41, 42, 51) and Doha Declaration IPRs, Customs & Regulatory Measures Reference is also made to International Covenant on Economic, Social and Cultural Rights Claimants call for clear separation of IPR-related issues from public health considerations Note: confusion about terminology is emphasized Follow-Up in EU: Customs Regulation (EU) 608/2013 Trademark Regulation (EU) 2015/2424 and Directive (EU) 2015/
15 III. IP in WTO Case Law: Arbitration & Cross-Retaliation 15
16 Good Offices, Conciliation & Mediation Art.5 DSU: May be requested at any time by any party to a dispute Voluntary procedures if parties so agree Concrete example - Paragraph 6 System: Chair Statement read out prior to adoption of Protocol Amending TRIPS summarizes key shared understandings, including: If any Member has concerns that the terms of the amendment have not been fully complied with, the Member may also utilize the good offices of the Director-General or Chair of the TRIPS Council, with a view to finding a mutually acceptable solution. 16
17 Arbitration in Selected IP Cases Art.21.3(c) Reasonable period to comply with panel/ab recommendations and rulings: Canada Term of Patent Protection (DS170) US Section 110(5) Copyright Act (DS160) Canada Pharmaceutical Products (DS114) Art.25 Arbitration as alternative means to settle disputes: US Section 110(5) Copyright Act (DS160): only use so far to determine level of nullification/impairment of benefits caused by violation established in panel report Art.22.6 Level of suspension proposed: US Section 110(5) Copyright Act (DS160): US objected to level of suspension of concessions proposed by EU and requested to refer to arbitration Arbitration proceeding suspended in 2002 January 2016: 149 status reports submitted by the US 17
18 Suspension of Obligations Preference: full implementation of Panel findings Suspension of concessions or other obligations ( retaliation ) can be authorized if a Member fails to implement recommendations within the period fixed or to offer acceptable compensation Applicable principles Article 22.3 DSU: Retaliation in the same sector If not practicable/effective Retaliation in other sectors under same agreement If not practicable/effective + circumstances serious enough Retaliation under another covered agreement: Cross-retaliation/TRIPS authorized in three cases 18
19 Cross-Retaliation in TRIPS EC Bananas III (DS27): May 2000: DSB authorizes Ecuador to suspend concessions, to the extent insufficient under GATT and GATS, under TRIPS in respect of related rights, geographical indications and industrial designs November 2012: Ecuador and 10 other Latin American countries notify mutually agreed solution US Gambling (DS285): January 2013: DSB authorizes suspension of concessions in respect of copyright and related rights, trademarks, industrial designs, patents, protection of undisclosed information (consistent with Arbitrator decision of December 2007) US Upland Cotton (DS267): November 2009: DSB authorizes Brazil to suspend concessions under TRIPS and GATS subject to certain conditions / thresholds October 2014: mutually agreed solution notified 19
20 IV. IP Expertise, Continuity and Information Resources: Experiences from Practice 20
21 AB Members, Panelists, WTO Staff Panelists Art.8.1 and 8.2 DSU: Chosen ad hoc, subject to a range of criteria Appellate Body Members Art.17.3 DSU: Persons of recognized authority, expertise in law, international trade and subject matter of covered agreements generally WTO Secretariat Art.27.1 DSU: To assist panels on legal, historical, procedural aspects and to provide secretarial and technical support Legal Affairs Division / Appellate Body Secretariat Substantive Divisions Objectives: Involve trade law and IP expertise Consider IP within broader policy context 21
22 Expertise of Panelists in Selected Cases Case Chairperson Member 1 Member 2 Australia Plain Packaging (DS434, 435, 441, 458, 467) Former Minister of Public Enterprises, Trade and Industry (South Africa) Former Minister of Trade, Health, Education (Barbados) Professor for IP (Switzerland) China Protection and Enforcement of IPRs (DS362) Uruguay Round TRIPS negotiator (New Zealand) Former WIPO official, IP lawyer and Professor for IP (Chile) Uruguay Round TRIPS negotiator, Chair of ASEAN WG on IP (Singapore) US Section 211 (DS176) Former Ambassador to WTO, TRIPS Council Chair (New Zealand) Professor for IP (Switzerland) Professor for EU Law and International Trade Law (Canada) EU Geographical Indications (DS174, 290) Former WTO Deputy DG, trade lawyer (Venezuela) Professor for International Trade Law, WTO AB Member (Korea) Former Director of IP (Hong Kong, China) Canada Pharmaceutical Products (DS114) Professor for International Trade Law (United States) Expert in international IP, former WIPO Assistant DG (Hungary) Senior Health Official (Mexico) US Section 110(5) Copyright Act (DS160) Former Ambassador to WTO, TRIPS Council Chair (Chile) Former trade and IP negotiator, became WTO AB Member later (India) Former Chair of Copyright Tribunal (Australia) 22
23 Sources of Information Third party submissions Art.13 DSU - factual information from any individual/body/source and expert opinions: WIPO negotiating history / factual information relevant to interpretation: US Section Section 110(5) Copyright Act US Section 211 Appropriations Act EC Trademarks and Geographical Indications China Protection and Enforcement of IPRs Australia Plain Packaging Bill WHO only in one case so far: Australia Plain Packaging Bill Request for factual information by arbitrators Amicus curiae briefs 23
24 V. WTO Capacity Building: Outlook 24
25 «TRIPS Jurisprudence» Project Objective: Understanding the wider legal context of TRIPS Providing a source of information for judges regarding the role of TRIPS in interpreting national law Proposed Tool: database with WTO Members jurisprudence Judicial decisions and similar legal findings that reference, rely on or cite specific TRIPS provisions when interpreting domestic law How to get there: Phase 1: in-house pilot phase Phase 2: cooperation with external partners Phase 3: continuity and analysis 25
26 Suggested as integral part of WTO Technical Assistance Plan Objectives: Preserve a certain degree of coherence regarding interpretation of TRIPS provisions Provide an overview of trends in IP litigation Exchange experiences Network to support «TRIPS jurisprudence» project Need to complement existing activities: WIPO: «Training of Judges» Project Judges and prosecutors CDIP/16/7 of 8 September2015 UNCTAD: TRIPS flexibilities relating to public health 26
27 VI. Conclusions 27
28 TRIPS Does Not Exist in a Vacuum Marrakesh Agreement Preamble Agreement on Trade-Related Aspects of IPRs: Link to trade clearly established Different from WIPO Conventions and Treaties Art.7 TRIPS: IPR protection and enforcement To promote technological innovation and transfer and dissemination of technology ( ) in a manner conducive to social and economic welfare ( ) Art.8 TRIPS: TRIPS-consistent measures Necessary to protect public health and nutrition and to promote public interest Doha Declaration on TRIPS and Public Health: TRIPS as part of wider national and international action 28
29 Issues & Challenges Complex and lengthy procedures: Cases are politically sensitive Complex Attract widespread interest Take usually more time to issue a report How to Design Optimal IP Judiciary remains an open question Optional approach for Members in Art.41.5 The unresolved question: should nonviolation and situation complaints apply to TRIPS? 29
Regional Comprehensive Economic Partnership. Intellectual Property Chapter and the Impact on Access to Medicines
MSF RCEP IP Chapter Technical Analysis NOVEMBER 2016 Regional Comprehensive Economic Partnership Intellectual Property Chapter and the Impact on Access to Medicines This briefing note details Médecins
The Estey Centre Journal of. International Law. and Trade Policy. The Provisions on Geographical Indications in the TRIPS Agreement
Volume 10 Number 1 2009/p. 50-64 esteyjournal.com The Estey Centre Journal of International Law and Trade Policy The Provisions on Geographical Indications in the TRIPS Agreement Matthijs Geuze 1 Senior
Fish or Fowl? The Nature of WTO Dispute Resolution under TRIPS
Annual Survey of International & Comparative Law Volume 12 Issue 1 Article 11 2006 Fish or Fowl? The Nature of WTO Dispute Resolution under TRIPS Anne Hiaring Follow this and additional works at: http://digitalcommons.law.ggu.edu/annlsurvey